Personalized psychiatry: many questions, fewer answers.
作者信息
Alda Martin
机构信息
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
出版信息
J Psychiatry Neurosci. 2013 Nov;38(6):363-5. doi: 10.1503/jpn.130221.
Abstract
摘要
相似文献
1
Personalized psychiatry: many questions, fewer answers.
J Psychiatry Neurosci. 2013 Nov;38(6):363-5. doi: 10.1503/jpn.130221.
2
Personalized medicine in psychiatry: ethical challenges and opportunities.
Dialogues Clin Neurosci. 2009;11(4):427-34. doi: 10.31887/DCNS.2009.11.4/kevers.
3
Precision and personalized assessment, diagnosis and treatment in psychiatry.
CNS Spectr. 2021 Aug;26(4):326-332. doi: 10.1017/S1092852920000139. Epub 2020 Mar 31.
4
Psychoanalysis in the era of precision psychiatry.
Asian J Psychiatr. 2020 Jan;47:101840. doi: 10.1016/j.ajp.2019.10.020. Epub 2019 Oct 16.
5
[Personalised medicine applied to mental health: Precision psychiatry].
Rev Psiquiatr Salud Ment. 2015 Jul-Sep;8(3):117-8. doi: 10.1016/j.rpsm.2015.03.003. Epub 2015 May 8.
6
Precision Psychiatry Meets Network Medicine: Network Psychiatry.
JAMA Psychiatry. 2017 Jul 1;74(7):665-666. doi: 10.1001/jamapsychiatry.2017.0580.
7
Update: healthcare reform - it's getting personal.
Per Med. 2017 Jul;14(4):281-283. doi: 10.2217/pme-2017-0026. Epub 2017 Jun 22.
8
Detours on the road to personalized medicine: barriers to biomarker validation and implementation.
JAMA. 2011 Nov 2;306(17):1914-5. doi: 10.1001/jama.2011.1605.
9
Ranting in 2017: Is It Working?
Diabetes Technol Ther. 2017 Feb;19(2):69-72. doi: 10.1089/dia.2017.0003. Epub 2017 Jan 12.
10
A Transdisciplinary Integrative Approach for Precision Psychiatry.
Adv Exp Med Biol. 2019;1192:399-428. doi: 10.1007/978-981-32-9721-0_20.
引用本文的文献
1
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder.
Brain Sci. 2025 Apr 23;15(5):430. doi: 10.3390/brainsci15050430.
2
Exploring gender impact on collaborative care planning: insights from a community mental health service study in Italy.
BMC Psychiatry. 2023 Nov 13;23(1):834. doi: 10.1186/s12888-023-05307-5.
3
Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept.
Int J Bipolar Disord. 2022 Aug 3;10(1):21. doi: 10.1186/s40345-022-00268-2.
4
Feasibility and acceptability of a novel telepsychiatry-delivered precision prescribing intervention for anxiety and depression.
BMC Psychiatry. 2022 Jul 19;22(1):483. doi: 10.1186/s12888-022-04113-9.
5
Investigating aberrantly expressed microRNAs in peripheral blood mononuclear cells from patients with treatment‑resistant schizophrenia using miRNA sequencing and integrated bioinformatics.
Mol Med Rep. 2020 Nov;22(5):4340-4350. doi: 10.3892/mmr.2020.11513. Epub 2020 Sep 15.
6
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.
Heliyon. 2020 May 20;6(5):e03990. doi: 10.1016/j.heliyon.2020.e03990. eCollection 2020 May.
7
Challenges and Future Prospects of Precision Medicine in Psychiatry.
Pharmgenomics Pers Med. 2020 Apr 23;13:127-140. doi: 10.2147/PGPM.S198225. eCollection 2020.
8
The functional variant rs334558 of is associated with remission in patients with depressive disorders.
Pharmgenomics Pers Med. 2018 Jul 20;11:121-126. doi: 10.2147/PGPM.S171423. eCollection 2018.
9
Deconstructing the mental health crisis: 5 uneasy pieces.
J Psychiatry Neurosci. 2016 Jun;41(4):219-21. doi: 10.1503/jpn.160101.
本文引用的文献
1
Pros and cons of specialised care in bipolar disorder: an international perspective.
Br J Psychiatry. 2013 Mar;202(3):170-1. doi: 10.1192/bjp.bp.112.118588.
2
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
PLoS Med. 2012;9(10):e1001326. doi: 10.1371/journal.pmed.1001326. Epub 2012 Oct 16.
3
Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study.
J Psychiatr Pract. 2012 Jul;18(4):269-80. doi: 10.1097/01.pra.0000416017.45591.c1.
4
The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers.
Br J Cancer. 2012 Mar 13;106(6):1100-6. doi: 10.1038/bjc.2012.60. Epub 2012 Feb 28.
5
Personalized medicine. New cystic fibrosis drug offers hope, at a price.
Science. 2012 Feb 10;335(6069):645. doi: 10.1126/science.335.6069.645.
6
Mutation-specific cystic fibrosis treatments on verge of approval.
Nat Med. 2011 Apr;17(4):396-7. doi: 10.1038/nm0411-396.
7
ITAREPS: information technology aided relapse prevention programme in schizophrenia.
Schizophr Res. 2008 Jan;98(1-3):312-7. doi: 10.1016/j.schres.2007.09.005. Epub 2007 Oct 24.
8
Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
J Affect Disord. 2007 Dec;104(1-3):185-90. doi: 10.1016/j.jad.2007.03.003. Epub 2007 Apr 17.
9
The value of medical spending in the United States, 1960-2000.
N Engl J Med. 2006 Aug 31;355(9):920-7. doi: 10.1056/NEJMsa054744.
10
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Am J Psychiatry. 2006 Jan;163(1):28-40. doi: 10.1176/appi.ajp.163.1.28.
Zotero 插件